JONATHAN TZU, MD
Ophthalmology Physician · HOUSTON, TX
Individual Active NPI 1962630335
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 812 | 42,807 | $7,839,378 | $4,042,946 | $3,174,237 |
| 2023 | 830 | 31,977 | $6,475,154 | $3,690,213 | $2,898,586 |
| 2022 | 802 | 16,670 | $5,137,038 | $3,404,604 | $2,670,576 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J2777 | Injection, faricimab-svoa, 0.1 mg | 28,380 | $34 | $27 |
| 92134 | Imaging of retina | 2,668 | $38 | $29 |
| J0178 | Injection, aflibercept, 1 mg | 2,248 | $825 | $657 |
| 92014 | Established patient complete exam of visual system | 2,045 | $120 | $84 |
| 67028 | Injection of drug into eye | 1,886 | $121 | $90 |
| 92202 | Extended exam of the back part of the eye with optic nerve drawing | 1,436 | $15 | $11 |
| J2778 | Injection, ranibizumab, 0.1 mg | 1,089 | $162 | $129 |
| 92201 | Extended exam of the back part of the eye with retinal drawing | 675 | $24 | $18 |
| J0177 | Injection, aflibercept hd, 1 mg | 496 | $332 | $264 |
| J9035 | Injection, bevacizumab, 10 mg | 407 | $68 | $54 |
| 92004 | New patient complete exam of visual system | 155 | $143 | $92 |
| 92020 | Exam of the internal drainage system of eye | 92 | $26 | $20 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Ophthalmology Physician | 207W00000X | ✓ | Q3301 | TX |
| Retina Specialist (Ophthalmology) Physician | 207WX0107X | Q3301 | TX |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Ophthalmology Physician providers in Texas
- NPI 1295817609
- NPI 1023436896
- NPI 1588815468
- NPI 1437254976
- NPI 1477290617
- NPI 1619491941
- NPI 1336405463
- NPI 1811519358
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.